INDIANAPOLIS, May 11, 2022 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today the U.S. Food and Drug Administration (FDA) has approved Olumiant (baricitinib) for the treatment of COVID-19 in…Original Article
FDA Approves Olumiant (baricitinib) Treatment for COVID-19 in Certain Hospitalized Adults
